KAPI

Introduction to Serialization, Track and Trace – June 12, 2025

Reports & Studies /

Executive Summary Serialization and track and trace are critical components in the pharmaceutical industry, designed to enhance the safety and integrity of the supply chain. Serialization refers to the process of assigning a unique identifier, typically a serial number, to each saleable unit of a product. This identifier allows for the precise tracking of individual […]

Introduction to Serialization, Track and Trace – June 12, 2025 Read More »

Unlocking the Power of Regulatory Reliance: Kenya’s Journey Towards Efficient and Harmonized Health Product Oversight

Expert Insights /

In the ever-evolving landscape of global health, regulatory authorities are increasingly recognizing the transformative potential of “regulatory reliance” – the act whereby the regulatory authority in one jurisdiction takes into account and gives significant weight to assessments performed by another regulatory authority or trusted institution, or to any other authoritative information, in reaching its own

Unlocking the Power of Regulatory Reliance: Kenya’s Journey Towards Efficient and Harmonized Health Product Oversight Read More »

Regulatory Reliance Workshop – March 20, 2025

Reports & Studies /

Executive Summary Introduction and Purpose The Regulatory Reliance Workshop held on March 20, 2025, in Nairobi, Kenya, brought together experts from the Pharmaceuticals and Medical Devices sectors to discuss Regulatory Reliance, its implementation, benefits, and challenges in Kenya. Among the participants included members of KAPI, MEDAK, representatives from the Pharmaceutical Society of Kenya, Federation of

Regulatory Reliance Workshop – March 20, 2025 Read More »

Webinar: Dissemination Session: Assessment of Regulatory Reliance in Kenya

Events /

Regulatory reliance is the act whereby the regulatory authority in one jurisdiction takes into account and gives significant weight to assessments performed by another regulatory authority or trusted institution, or to any other authoritative information, in reaching its own decision. The relying authority remains independent, responsible, and accountable for the decisions taken, even when it relies

Webinar: Dissemination Session: Assessment of Regulatory Reliance in Kenya Read More »

KAPI Report: Collaborating To Achieve Universal Health Coverage (UHC)

Leave a Comment / Reports & Studies /

KAPI was honored to host several stakeholders during the launch of the KAPI Report on Friday 23rd July, 2021. Among those who graced our occasion, The CAS, Ministry of Health, Dr. Mercy Mwangangi, The CEO, Pharmacy and Poisons Board, Dr. Fred Siyoi, Assistant Director General, IFPMA, Greg Perry, The Chair, Kenya Medical Practitioners and Dentists Council (KMPDC),

KAPI Report: Collaborating To Achieve Universal Health Coverage (UHC) Read More »

KAPI Leadership Pays a Courtesy visit to the PS, Ministry of Health

Leave a Comment / Events /

On Tuesday 26th January 2021 the Kenya Association of Pharmaceutical Industry (KAPI) executive board led by the Chairperson, Willy Soriney paid a courtesy visit to the Principal Secretary, Ministry of Health Madam Susan Mochache. This was part of the associations’ stakeholder engagement mechanisms aimed at fostering collaborative spirit for the advancement of the health agenda for

KAPI Leadership Pays a Courtesy visit to the PS, Ministry of Health Read More »

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya

Leave a Comment / Events /

As a membership organization driven by tenets of social responsibility and commitment to public health, in the wake of COVID-19 it is in our purview to drive a common agenda to flatten the curve of transmission, build concerted efforts to ensure uninterrupted supply of medicines, diagnostics and healthcare technologies. Additionally, our member companies have been

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya Read More »

Welcome to KAPI - Industry Alliance of Health Products and Technologies

Join Us
X